LEADER 03109nam 2200493 450 001 9910480044303321 005 20201023133920.0 010 $a1-906897-43-3 035 $a(CKB)4100000011338203 035 $a(MiAaPQ)EBC6246567 035 $a(EXLCZ)994100000011338203 100 $a20201023d2017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 04$aThe death of public knowledge? $ehow free markets destroy the general intellect /$fedited by Aeron Davis 210 1$aCambridge, Massachusetts :$cGoldsmiths Press,$d2017. 215 $a1 online resource (177 pages) $cillustrations 225 0 $aPERC papers 311 $a1-906897-39-5 320 $aIncludes bibliographical references and index. 327 $aSection one. Public news media -- Does public media enhance citizen knowledge? : sifting through the evidence / Toril Aalberg -- The impact of austerity on the Greek news media and public sphere / Aris Nikolaidis -- Impoverishing the mediated public sphere in Aotearoa New Zealand / Wayne Hope -- Public-commercial hybridity at BBC world online / Kate Wright -- The new American media landscape / Rod Benson -- Section two. Public knowledge in Britain -- The autonomous school, the strong state, the problems of education / Ken Jones -- The treasury view of higher education: variable human capital investment / Andrew McGettigan -- The coalition government's cuts to legal aid : who is counting the cost? / Roger Smith -- Public libraries in the age of austerity : the gloves are off / Ian Anstice -- Section three. The corruption of news and information in markets -- The edge : investment banks and information flows in public markets / Philip Augar -- The libor scandal : mediation and information issues / Peter Thompson -- The press, market ideologies and the Irish housing crash / Henry Silke -- Section four. The encroachment of private knowledge on public policy-making -- The corporate takeover of economic discourse in Korea / Bong-hyun Lee -- The tropes of unlearning : UK responses to outsourcing fiascos / Mick Moran and Karel Williams -- Meet the new American influence elites / Janine Wedel -- Public knowledge and health policy / Colin Leys -- Conclusion: manifesto for public knowledge / Des Freedman and Justin Schlosberg. 606 $aEducation and state$xEconomic aspects$zGreat Britain 606 $aMass media$xEconomic aspects 606 $aInformation policy$xEconomic aspects 606 $aMass media policy 606 $aKnowledge, Sociology of 608 $aElectronic books. 615 0$aEducation and state$xEconomic aspects 615 0$aMass media$xEconomic aspects. 615 0$aInformation policy$xEconomic aspects. 615 0$aMass media policy. 615 0$aKnowledge, Sociology of. 676 $a001 702 $aDavis$b Aeron 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910480044303321 996 $aThe death of public knowledge$92481409 997 $aUNINA LEADER 00809nam0-2200289 --450 001 9910637893303321 005 20230118102412.0 010 $a88-8483-442-2 010 $a978-88-8483-442-3 100 $a20230118d2007----kmuy0itay5050 ba 101 0 $aita 102 $aIT 105 $a 001yy 200 1 $aGovernance$eteorie, principi, modelli, pratiche nell'era globale$fa cura di Antonino Palumbo e Salvo Vaccaro 210 $aMilano$cMimesis$d2007 215 $a301 p.$d21 cm 225 1 $aMimesis. Eterotopie 610 0 $aGoverno 702 1$aVaccaro,$bSalvo 702 1$aPalumbo,$bAntonino 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910637893303321 952 $aLEPORE 450$bLEPORE 450$fFARBC 959 $aFARBC 996 $aGovernance$969830 997 $aUNINA LEADER 04624nam 2200601 450 001 9910818732603321 005 20230213215339.0 010 $a1-118-79391-9 010 $a1-118-79392-7 035 $a(CKB)3280000000033630 035 $a(EBL)1887752 035 $a(SSID)ssj0000951315 035 $a(PQKBManifestationID)11603810 035 $a(PQKBTitleCode)TC0000951315 035 $a(PQKBWorkID)10893241 035 $a(PQKB)10898223 035 $a(MiAaPQ)EBC1887752 035 $a(Au-PeEL)EBL1887752 035 $a(CaPaEBR)ebr10997612 035 $a(OCoLC)894581169 035 $a(EXLCZ)993280000000033630 100 $a20150108h19831983 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aClinical trials $ea practical approach /$fStuart J. Pocock 210 1$aChichester, England :$cJohn Wiley & Sons,$d1983. 210 4$dİ1983 215 $a1 online resource (280 p.) 225 0 $aA Wiley medical publication Clinical trials 300 $aDescription based upon print version of record. 311 1 $a0-471-96883-8 311 1 $a0-471-90155-5 320 $aIncludes bibliographical references and index. 327 $aCover; Title Page; Contents; Preface; 1. Introduction: The Rationale of Clinical Trials; 1.1 Types of clinical trial; 1.2 Controlled clinical trials and the scientific method; 1.3 An example of a clinical trial for primary breast cancer; 2. The Historical Development of Clinical Trials; 2.1 Clinical trials before 1950; 2.2 Clinical trials since 1950; 2.3 Cancer chemotherapy in the United States; 2.4 Treatment of acute myocardial infarction; 2.5 The pharmaceutical industry; 3. Organization and Planning; 3.1 The protocol; 3.2 Administration, staff and finance; 3.3 Selection of patients 327 $a3.4 Treatment schedules 3.5 Evaluation of patient response; 4. The Justification for Randomized Controlled Trials; 4.1 Problems with uncontrolled trials; 4.2 Problems with historical controls; 4.3 Problems with concurrent non-randomized controls; 4.4 Is randomization feasible?; 5. Methods of Randomization; 5.1 Patient registration; 5.2 Preparing the randomization list; 5.3 Stratified randomization; 5.4 Unequal randomization; 6. Blinding and Placebos; 6.1 The justification for double-blind trials; 6.2 The conduct of double-blind trials; 6.3 When is blinding feasible?; 7. Ethical Issues 327 $a7.1 Medical progress and individual patient care 7.2 Informed patient consent; 8. Crossover Trials; 8.1 Within-patient comparisons; 8.2 The two-period crossover design; 8.3 The analysis and interpretation of crossover trials; 8.4 Multi-period crossover designs; 9. The Size of a Clinical Trial; 9.1 Statistical methods for determining trial size; 9.2 The realistic assessment of trial size; 9.3 The inadequacy of small trials; 9.4 Multi-centre trials; 9.5 The number of treatments and factorial designs; 10. Monitoring Trial Progress; 10.1 Reasons for monitoring; 10.2 Interim analyses 327 $a10.3 Repeated significance testing: group sequential designs 10.4 Continuous sequential designs; 11. Forms and Data Management; 11.1 Form design; 11.2 Data management; 11.3 The use of computers; 12. Protocol Deviations; 12.1 Ineligible patients; 12.2 Non-compliance and incomplete evaluation; 12.3 Inclusion of withdrawals in analysis; 13. Basic Principles of Statistical Analysis; 13.1 Describing the data; 13.2 Significance tests; 13.3 Estimation and confidence limits; 14. Further Aspects of Data Analysis; 14.1 Prognostic factors; 14.2 The analysis of survival data; 14.3 Multiplicity of data 327 $a15. Publication and Interpretation of Findings 15.1 Trial reports and their critical evaluation; 15.2 An excess of false-positives; 15.3 Combining evidence and overall strategy; References; Index 330 $aThis comprehensive, unified text on the principles and practice of clinical trials presents a detailed account of how to conduct the trials. It describes the design, analysis, and interpretation of clinical trials in a non-technical manner and provides a general perspective on their historical development, current status, and future strategy. Features examples derived from the author's personal experience. 606 $aClinical trials 615 0$aClinical trials. 676 $a615/.7/0724 700 $aPocock$b Stuart J.$0519288 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818732603321 996 $aClinical trials$951093 997 $aUNINA